Search clinical trials for: MT-5111 (experimental study drug)

Total 4770 results

Molecular Templates, Inc.

Terminated

Study of MT-5111 in HER2-positive Solid Tumors (MT-5111)

HER2-positive Solid Cancers

United States, Australia, New Zealand
Assistance Publique - Hôpitaux de Paris

Completed

Cancer and Hearing Loss Related in Children (OTOPLAT)

Hearing Loss | Cancer in Children

France
Mitsubishi Tanabe Pharma Corporation

Recruiting

A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL

Diffuse Large B-Cell Lymphoma

Japan
University of Washington

Recruiting

Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies

Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Post-Transplant Lymphoproliferative Disorder | Refractory Mantle Cell Lymphoma | Recurrent Follicular... and other conditions

United States
Gdansk University of Physical Education and Sport

Enrolling by invitation

Influence of Supervised Stabilization Exercises on Postural Control in Patients After Spine Surgery.

Low Back Pain

Poland
Huang Xiaolin

Unknown

RCT of Addition of 3D Posture Corrective Orthosis to A Multimodal Program of Treatment Of Chronic Postural Neck Pain.

Neck Pain

China
VA Office of Research and Development

Active, not recruiting

Efficacy of a Coupler-based Fitting Approach for Experienced Users Receiving Replacement Hearing Aids

Hearing Loss

United States
British Columbia Cancer Agency
Canadian Cancer Society (CCS); SignalChem Lifesciences Corporation

Recruiting

A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX (SLC-0111-17-01)

Metastatic Pancreatic Ductal Adenocarcinoma

Canada
Abbott Nutrition

Terminated

Infants Fed an Amino Acid-based Formula

Food Allergy

United Kingdom
Qlaris Bio, Inc.

Recruiting

Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients

Primary Open Angle Glaucoma of Both Eyes | Primary Open Angle Glaucoma (POAG) | Primary Open-Angle Glaucoma, Unspecified Eye | Ocular Hypertension (OHT)

United States
CARDIAGS

Completed

Evaluation of Cardiags Trimod for Analysis of Cardiac Activity (EVALTRIMOD)

Rhythm; Abnormal | Murmur, Heart

France
Hasan Kalyoncu University

Not yet recruiting

Evaluation of the Effectiveness of Manual Therapy in Patients With Knee Osteoarthritis

Osteoarthritis, Knee

Turkey
National University of Singapore

Recruiting

Probiotic Intervention on Gut Microbiota and Cognitive Functioning in Older Adults With a Mild Cognitive Impairment

Mild Cognitive Impairment

Singapore
Lenstec Incorporated

Completed

Lenstec Tetraflex Accommodating Posterior Chamber Intraocular Lens (IOL) Clinical Investigation

Cataract
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency

Malabsorption Syndromes | Cystic Fibrosis | Steatorrhea | Exocrine Pancreatic Insufficiency

United States, Canada
Aydin Adnan Menderes University

Completed

Prenatal Pilates Assisted Childbirth Preparation Training and Incontinence

Incontinence, Urinary | Training Group, Sensitivity

Turkey
Mitsubishi Tanabe Pharma Corporation

Completed

Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants

Healthy

Australia, South Africa
Mannkind Corporation

Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma.

Advanced Melanoma | Stage III and IV Melanoma

United States
Abbott Nutrition

Withdrawn

Evaluation of a Nutritional Supplement for People With Type 2 Diabetes.

Diabetes

United States
Abbott Nutrition

Completed

Evaluation of a Nutritional Product for People With Type 2 Diabetes

Diabetes

United States
Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria

Diabetic Nephropathy

Lithuania, Romania, Bulgaria, Hungary, Slovakia
Mitsubishi Tanabe Pharma Corporation

Completed

Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients

Systemic Lupus Erythematosus

Japan
Molecular Templates, Inc.

Terminated

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL (MT-3724NHL001)

Leukemia, Lymphocytic, Chronic, B-Cell | Diffuse Large B Cell Lymphoma | Blood Cancer | Hematological Malignancy | Small Lymphocytic Leukemia | Non-Hodgkin's B-cell Lymphoma

United States, Canada, Georgia, Belarus, Spain, Israel, Moldova, Republic of, Poland, Serbia, Ukraine
Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR

Diabetic Nephropathy

Romania, Bulgaria, Hungary, Poland, Czech Republic, Slovakia
Abbott Nutrition

Completed

Growth of Infants Fed an Elemental Medical Food

Healthy Infants

United States
The Hospital for Sick Children

Completed

Uptake and Utilization of Amino Acids by Splanchnic Bed

Healthy Males

Canada
Myeloid Therapeutics

Suspended

A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL (IMAGINE)

Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Lymphoma, T-Cell, Peripheral | Cell Therapy | Adoptive Cellular Immunotherapy

United States
Toray Industries, Inc

Terminated

Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis

Uremic Pruritus

United States
Mitsubishi Tanabe Pharma Corporation

Recruiting

An Exploratory Study of MT-2990 in Patients With AAV

Antineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV)

Japan
Molecular Templates, Inc.

No longer available

Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell Lymphoma

Non-Hodgkin's B-cell Lymphoma

United States
Mannkind Corporation

Terminated

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

Stage IV Melanoma | Stage III Melanoma

United States
Michele Tinazzi, MD, PhD
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona; IRCCS Ospedale...

Recruiting

Study of Biomorkers and Rehabilitation Strategies in Functional Motor Disorders (FMD)

Functional Motor Disorders

Italy
Molecular Templates, Inc.

Withdrawn

Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Small Lymphocytic Leukemia | Chronic B-cell Lymphocytic Leukemia
PsiOxus Therapeutics Ltd
Veeda Oncology

Completed

A Clinical Study With MT-102 in Subjects With Cancer Cachexia

Cancer Cachexia

Malaysia, India, Germany
Mannkind Corporation

Completed

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
Kenneth Hargreaves

Withdrawn

Comparison of Tissue in Regenerative Endodontic Procedures and Apexification

Dental Pulp Regeneration

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan

Anemia; Hemodialysis Dependent Chronic Kidney Disease

Japan
Instituto de Investigación Sanitaria de la Fundación...

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells (FISPAC)

Anal Fistula

Spain
Molecular Templates, Inc.

Terminated

A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

United States
Molecular Templates, Inc.

Terminated

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Lenalidomide for the Treatment of Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (MT-3724_NHL_003)

Non-hodgkin Lymphoma

United States
BeiGene

Active, not recruiting

Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies

Mature B-cell Malignancies

Japan
Oklahoma State University

Recruiting

Gut Permeability-related Inflammation and Cardiovascular Disease Risk in Normal-weight and Metabolically Healthy Obesity

Obesity

United States
Mitsubishi Tanabe Pharma Corporation

Completed

A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients

Seasonal Allergic Rhinitis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Safety and Efficacy of MT-4666

Alzheimer's Disease

Japan
Mitsubishi Tanabe Pharma Corporation

Terminated

Safety Study of MT-4666 in Subjects With Alzheimer's Disease

Alzheimer's Disease

Japan
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Promoting HPV Vaccination Among Young Adults in Texas

HPV | Related Malignancy | Related Carcinoma

United States
Mitsubishi Tanabe Pharma Corporation

Completed

A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM)

HTLV-1-Associated Myelopathy (HAM)

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males

Healthy Adult Males

Japan
Mitsubishi Tanabe Pharma America Inc.

Completed

Relative Bioavailability and Drug-drug Interaction Study With MT-7117 and a Proton Pump Inhibitor (MT-7117 BA DDI)

Healthy Volunteer

Germany
Mitsubishi Tanabe Pharma Corporation

Completed

Drug Interaction Study of Warfarin and MT-3995

Healthy

Germany

Search clinical trials for: MT-5111 (experimental study drug)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations